News | January 26, 2015

Japanese Distributor Named for ViewRay’s MRI-Guided Radiation Therapy System

MRIdian system is an MRI-guided radiation therapy system that images and treats cancer patients simultaneously

Radiation therapy, Itochu, ViewRay, MRIdian

Image courtesy of ViewRay

January 26, 2015 — ViewRay announced that it has entered into an exclusive distributor agreement with Itochu Corporation to sell its MRI-guided radiation therapy system for the treatment of cancer in Japan. ViewRay’s technology, the MRIdian system, is the world’s first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously.

The MRIdian system is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous MRI and radiation therapy delivery. With continuous soft-tissue imaging, clinicians can more clearly see the cancer target, monitor where the actual radiation dose is being delivered, and adapt to changes in the patient’s anatomy – all in real time, providing a more precise and personalized cancer treatment option.

Initial interest in MRI-guided radiation therapy is already growing in Japan following the December 2014 annual JASTRO meeting where former ASTRO president, Michael Steinberg, M.D., presented on the advanced capabilities of the technology to more than 250 people. For more information: www.viewray.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more